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Four colicin A double-cysteine mutants possessing a
disulfide bond in their pore-forming domain were constructed to study the translocation and the pore formation of colicin A. The disulfide bonds connected a-helices 1 and 2, 2 and 10, 3 and 9, or 3 and 10 of the poreforming domain. The disulfide bonds did not prevent the
colicin A translocation through the Escherichia coli envelope. However, the mutated colicins were able to exert
their in vivo channel activity only after reduction of
their disulfide bonds. In vitro studies with brominated
phospholipid vesicles and planar lipid bilayers revealed
that the disulfide bond that connects the a-helices 2 and
10 prevented the colicin A membrane insertion, whereas
the other double-cysteine mutants inserted into lipid
vesicles. The disulfide bonds that connect either the
a-helices 1 and 2 or 3 and 10 were unable to prevent the
formation of a conducting channel in presence of membrane potential. These results indicate that a-helices 1,
2, 3, and 10 remain at the membrane surface after application of a membrane potential.

Colicin A is a bacteriocin that kills sensitive Escherichia coli
cells by forming voltage-gated ion channels in cytoplasmic
membranes. Like many toxins, colicin A is organized into structural domains, each of them carrying one function associated
with the toxin’s lethal activity (1). The N-terminal domain is
involved in the translocation through the E. coli envelope, the
central domain is responsible for the binding to a receptor on
the bacterial surface, and the C-terminal domain possesses the
pore-forming activity. The soluble form of this C-terminal domain obtained by mild proteolytic digestion was crystallized,
and its three-dimensional structure was determined at 2.4 Å
resolution. This molecule consists of a bundle of eight amphipathic a-helices surrounding two hydrophobic a-helices
completely buried within the protein (2, 3).
In vitro, the pore formation is divided into several steps
including a voltage-independent membrane insertion and a
voltage-dependent channel opening (4). The first step is initiated by an electrostatic interaction between colicin A and negatively charged phospholipids (5–7). Two models have been
proposed to picture the conformational changes required for
* This study was supported by the Centre National de la Recherche
Scientifique, by the Australian Research Council, and by the Spanish
Ministry of Education and Science. The costs of publication of this
article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
i To whom correspondence should be addressed. Tel.: 33-91-16-41-17;
Fax: 33-91-71-21-24; E-mail: baty@ibsm.cnrs-mrs.fr.

the colicin membrane insertion. In the first model, called the
“umbrella model,” the three layers of helices that form the
soluble structure are rearranged so that the hydrophobic hairpin of helices 8 and 9 traverses the membrane, whereas the
helical pair 1 and 2 folds out on the surface in the opposite
direction to helices 4 –7 (8 –10). In the second model, called the
“penknife model,” the hydrophobic helical hairpin lies parallel
to the membrane plane (4, 11, 12).
Colicin channels inserted in planar lipid bilayers are opened
by applying a trans-negative potential over a certain threshold
voltage (13, 14). The voltage gating of colicins involves the
translocation of parts of the protein across the membrane exposing different domains to the cis and trans solutions in the
open and closed states (15, 16). Recently, Slatin et al. (17) have
demonstrated that large domains of colicin Ia can reversibly
flip across the membrane.
In a previous paper, we have discussed the effect of introducing four disulfide bonds in the colicin A pore-forming domain in order to analyze the voltage independent membrane
insertion and the voltage dependent channel opening of the
colicin A pore formation (4). These results suggested that the
a-helices 8 and 9 did not cross the membrane without membrane potential and that the channel opening allowed drastic
changes in the conformation of the pore-forming domain. In
this paper we have used the same methodology to study the
role of the first three helices of the colicin A pore-forming
domain. The new double-cysteine mutants were tested for their
capacity to promote K1 efflux from E. coli cells, to insert into
lipid vesicles, and to form a conducting channel in planar lipid
bilayers. The results obtained confirm the penknife model and
suggest that the first three helices of the colicin A pore-forming
domain are required to complete the colicin A translocation.
EXPERIMENTAL PROCEDURES

Bacterial Strains and Media—The E. coli strain W3110 and plasmid
pLR1 have been described (4). The W3110 strain containing the various
mutated plasmids was grown in LB medium and used for construction
of the mutants. In order to measure the K1 efflux induced by the
colicin’s activity, E. coli W3110 strain was grown at 37 °C to an A650 of
0.5 (5 3 108 cells/ml) in LB medium, washed, resuspended in 100 mM
sodium phosphate buffer (pH 6.8), and kept on ice at a density of 5 3
1010 cells/ml.
DNA Manipulation—All single-cysteine mutants were obtained by
the insertion of paired oligonucleotides into the plasmid pLR1 between
restriction sites (4) and were sequenced. The unique restriction sites
used are listed in Table I. The double-cysteine mutants were constructed by fragment exchange between plasmids containing the singlecysteine mutants. The unique restriction sites and the plasmids used
are listed in Table I.
Proteins Purification and Sulfhydryl Titration—Bacterial strains
containing plasmids were induced with 300 ng/ml of mitomycin C. All
single or double-cysteine mutants were expressed at the same level as
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TABLE I
Cysteine mutants
The restriction sites and the plasmids used to introduce cysteine
residues in the a-helices of the colicin A C-terminal domain are indicated. The sequence of the C-terminal domain has been published
previously (4).
Plasmids

Mutations

Helices

TABLE II
Predicted geometries of engineered disulfides in colicin A
Colicin A pore-forming domain crystallizes as two monomers in the
asymmetric unit of the unit cell. Calculations were performed on both.
23
x is the Cb1-Sg1-Sg2-Cb2 dihedral angle. Energy of the disulfide
bond is determined as defined by Hazes and Dijkstra (23).

Restriction sites

Monomer A
Mutants

OH1
OJ7
PB7

I19C
A42C
I19C/A42C

OJ4
OP1
PA1

K33C
H2a
AvrII/BspMII
E198C
H10b
MluI/EagI
K33C/E198C H2/H10 BstEII/HindIII from OP1 to OJ4a

OL3
OM3
OQ3

I66C
A181C
I66C/A181C

H3b
H9
H3/H9

OK3
ON1
OR8

S62C
A192C
S62C/A192C

H3a
BspMII/SfiI
H10a
NarI/MluI
H3/H10 BstEII/HindIII from ON1 to OK3a

a

H1
H2b
H1/H2

XbaI/AvrII
AvrII/BspMII
AvrII/HindIII from OJ7 to OH1a

BspMII/SfiI
NheI/NarI
BstEII/HindIII from OM3 to OL3a

HindIII is a unique site of pColA9 (41).

the wild type colicin A. Colicin A single-cysteine mutants and doublecysteine mutants were purified from the extracellular medium, and
their thiol groups were titrated as described previously (4).
In Vivo Activity—In vivo activities of the colicins were determined by
measuring the changes of the K1 concentration in the external medium
with a K1 valinomycin-selective electrode as described previously (18).
To increase the intracellular potassium concentration above 400
nmol/mg dry weight, the cells (2 3 109/ml) were incubated for 5 min at
37 °C in 100 mM sodium phosphate buffer (pH 7.2) containing glucose
(0.2%, w/v) and 0.5 mM KCl. The purified double-cysteine mutants were
reduced with 5 mM DTT1 at 37 °C for 10 min in 50 mM Tris-HCl (pH 8.0)
buffer and added to the E. coli cells at a multiplicity (number
of colicins/cell) of 400. The lag times were calculated as described
previously (19).
Insertion Kinetics of Colicin A into Phospholipid Vesicles—The
quenching of the intrinsic fluorescence of colicin A by Br-DOPG vesicles
was used to follow the membrane insertion kinetics of colicin A (20). The
synthesis of Br-DOPG, the vesicle preparations, and the fluorescence
measurements were carried out as described previously (4, 20, 21).
In Vitro Activity—Planar bilayers were formed in a small hole connecting two aqueous compartments using the Mueller-Rudin technique
(22). The phospholipids were Sigma Type II-S soybean L-a phosphatidylcholine. The hole was pretreated with a solution of phospholipids in
decane (10 mg/ml). Membranes were then formed with the same solution by the brush technique. All conductance measurements were performed in 1 M NaCl, 10 mM Tris acetate (pH 4.0), 2 mM CaCl2. Known
voltages were applied across the membrane, before colicin addition, to
the cis side compartment under stirring, and the resulting current
responses were measured. The trans compartment was connected to
virtual ground. 50 ng/ml of wild type or double-cysteine mutants,
treated with or without DTT, were added to the cis side of a lipid
bilayer. Alternatively, 1 ng of protein could be added to record unitary
currents.
RESULTS

Choice of Sites for Engineered Disulfides—Potential sites for
cysteine residue pairs that might form disulfide bonds were
selected using the method of Hazes and Dijkstra (23). Briefly,
potential residue pairs were initially selected on the basis of
appropriate Cb-Cb distances. Sulfur positions were generated
for these residues, and it was checked whether certain stereochemical criteria were obeyed. A major criterion was that the
x23 angles could not deviate by more than 30 ° from the observed preferences. Selected pairs were subjected to energy
minimization and energetically favorable conformations were
chosen (less than 10 kcal/mol) (Table II). Success of this method
relies on the assumption that main chain conformations are
very similar between wild type and mutant. Calculations were
based on the refined model of the colicin A C-terminal domain
1
The abbreviations used are: DTT, dithiothreitol; Br-DOPG, brominated dioleoylphosphatidylglycerol.

H1/H2
H2/H10
H3/H9
H3/H10

Monomer B

x23

Energy

x23

Energy

degrees

kcal/mol

degrees

kcal/mol

272
126
293
130

3.4
5.1
2.7
5.9

286
135
2105
126

3.5
5.8
3.3
5.7

(3). This model has been refined to an R-factor of 0.18 at 2.4 Å
resolution with good stereochemistry.
The disulfide bonds were chosen to connect the first three
helices of the colicin A C-terminal domain to the neighboring
helices. These bonds, Ile19 3 Cys/Ala42 3 Cys (H1/H2), Lys33
3 Cys/Glu198 3 Cys (H2/H10), Ile66 3 Cys/Ala181 3 Cys
(H3/H9), and Ser62 3 Cys/Ala1923 Cys (H3/H10) connected
helices 1 and 2, helices 2 and 10, helices 3 and 9, and helices 3
and 10, respectively (Fig. 1). To introduce these disulfide bonds,
we used the LR1 plasmid, which encodes the entire colicin A
protein (4). From this plasmid, cassette mutagenesis was performed to introduce the cysteine residues (Table I). All the
mutant proteins were expressed at the wild type level and were
purified.
Disulfide Bond Formation—Disulfide bond formation of the
double-cysteine mutants was analyzed by sulfhydryl titrations.
The purified proteins were first denatured in 8 M urea in order
to expose the buried thiol groups, and then they were incubated
with or without a reducing agent such as DTT and finally
incubated with a thiol-specific reagent monobromobimane. The
thiol groups were titrated with the monobromobimane only
after the reduction of the double-cysteine mutants by DTT (Fig.
2). The double-cysteine mutants that reacted with the monobromobimane migrated slower than either the wild type or the
nonreactive double-cysteine mutants in a nonreducing 7 M urea
gel (Fig. 2). These results indicate that without a reducing
agent the two thiol groups of the double-cysteine mutants form
a disulfide bond.
The Disulfide Bonds Inhibit the in Vivo Colicin A Activity—
The effect of the disulfide bonds on the colicin A pore-forming
activity were tested in E. coli cells by using a K1/valinomycin
selective electrode. It has been previously described that colicin
A, when added to E. coli sensitive cells, induced an efflux of
cytoplasmic K1 that was correlated with the activity of the
pore. The rate of this K1 efflux saturated at about 400 molecules/cell (18). At this multiplicity, the double-cysteine mutants
did not cause a K1 efflux in contrast to the corresponding
single-cysteine mutants (Table III). However, when these inactive mutants were preincubated with 5 mM DTT before their
addition to the cells, their ability to induce a cytoplasmic K1
efflux was restored to the wild type level (Table III). This result
indicates that the disulfide bonds block the in vivo colicin A
pore-forming activity.
The Disulfide Bonds Do Not Prevent the Colicin A Translocation through the E. coli Envelope—Different steps can be
blocked by the disulfide bonds. We examined the effect of the
disulfide bond on the colicin A reception on the bacterial surface and translocation through the E. coli envelope. The K1
efflux induced by colicin A is preceded by a lag that corresponds
to the time required for its binding to BtuB and OmpF and for
its translocation through the envelope (18). At a multiplicity of
400 and at 37 °C, the lag time equaled 27 s for the wild type
colicin A and 29, 32, 28, and 30 s, respectively, for the H1/H2,
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TABLE III
In vivo activities of the cysteine mutants
The ability to induce a K1 efflux of the purified cysteine mutants and
colicin A wild type, preincubated with or without 5 mM DTT was
investigated on the E. coli W3110-sensitive strain at the multiplicity of
400 molecules/cell. The initial rate of K1 efflux was determined in the
linear part of the K1 efflux curve as previously described (18).
Initial rate of K1 efflux
Mutants

2DTT

1DTT
21

nmol min

FIG. 1. Positions of the disulfide bonds in the colicin A Cterminal domain. Ribbon plot of the colicin A C-terminal domain
displaying the disulfide bonds. The 10 a-helices are numbered H1
through H10. Coordinates of the colicin A C-terminal domain are deposited in the Brookhaven Protein Data Bank (ICOL). This figure was
produced by the computer program MOLSCRIPT (40).

FIG. 2. Sulfhydryl titrations and electrophoretic migration of
double-cysteine mutants. Purified colicins (2 mg/ml) were denatured
in 8 M urea and incubated with or without 25 mM DTT at 37 °C for 4 h,
and then the sulfhydryl contents (free SH) were determined by reacting
the denatured colicins with a 5-fold molar excess of monobromobimane
for 2 h at room temperature. Colicin samples (3 mg) were run on a 7%
SDS-polyacrylamide, 7 M urea gel (lacking reducing agent). The arrows
indicate the position of the reduced (red) versus oxidized (ox) disulfide
colicins. WT, wild type.

H2/H10, H3/H9, and H3/H10 mutants whose disulfide bonds
were reduced before their addition to the cells (data not shown).
After incubation of the oxidized colicins with cells during 1 min
at the multiplicity of 400 and at 37 °C, the addition of 5 mM
DTT resulted in a K1 efflux whose initial rate was identical to
that of the colicin mutant reduced in vitro (data not shown).
Interestingly, the time elapsing between the DTT addition and
the K1 efflux equaled 8 –10 s (data not shown). This time is
shorter than the time required for the colicins translocation
(see above). It is likely that this time represents the time
needed for DTT action. Indeed, the time required for full in
vitro reduction of the mutants treated with 5 mM DTT equaled
3– 8 min (data not shown). Because colicin A is unfolded during
its translocation, the time required for DTT action is shorter in
vivo than in vitro (19, 24). This result indicates that the mutated colicins were fully translocated despite the presence of
their disulfide bonds.
The Voltage-independent Membrane Insertion of the Colicin
A Is Only Blocked by the Disulfide Bond That Connects Helices
2 and 10 —The ability of the disulfide bonds to prevent the
colicin A membrane insertion was tested with brominated
phospholipid vesicles. Liposomes made of brominated phospholipids are an efficient system for studying colicin A membrane

21

mg

Wild type

400

410

H1
H2b
H1/H2

390
380
9

420
370
320

H2a
H10b
H2/H10

370
390
15

380
380
335

H3b
H9
H3/H9

410
420
20

390
410
425

H3a
H10a
H3/H10

390
400
15

400
380
400

insertion. Indeed, the bromine atoms located at the midpoint of
the phospholipid acyl chain quench the intrinsic fluorescence of
the inserted colicin A (20, 21). The quenching is due to a
collisional mechanism or to a short distance resonance energy
transfer (25). From these quenching experiments, the insertion
kinetic constant (k) and the residual tryptophan fluorescence
(RF) can be calculated (4).
The disulfide bond that connects helices 2 and 10 was the
only one able to prevent the colicin A membrane insertion (Fig.
3, top). Reduction of the disulfide bond with DTT restored the
ability of the H2/H10 mutant to insert into Br-DOPG vesicles.
The H1/H2, H3/H9, and H3/H10 mutants were able to insert
into Br-DOPG vesicles without preincubation with DTT (Fig. 3,
bottom). The insertion kinetic constant and the residual fluorescence of the oxidized H3/H9 and H3/H10 mutants and reduced H2/H10 mutant were quite similar to those of the colicin
A wild type (Table IV). However, the insertion kinetic constant
of the oxidized H1/H2 mutant was higher as compared with the
wild type. A similar behavior was encountered previously with
cysteine mutation, which destabilized the colicin A conformation (26) and favored its membrane insertion (4, 11).
The Disulfide Bond That Connected Helices 1 and 2 and
Helices 3 and 10 Did Not Prevent the Ionic Channel Formation—The ability of the double-cysteine mutants to form functional ionic channels when incorporated in lipid bilayer was
evaluated with the planar bilayer technique. As described previously (14), adding the wild type colicin A to the cis side of the
bilayer resulted in voltage-dependent currents. The current
activated at large depolarizations (e.g., 190 mV in Fig. 4A) and
deactivated upon repolarization. Both activating and deactivating rates were strongly voltage-dependent. Once incorporated
in a functional state, the channel opened and closed at a rate
determined by the membrane polarization.
The H1/H2 and H3/H10 mutants were found able to form
functional channels without the need of preincubation with
DTT (Fig. 4B). The overall behavior of the resulting macroscopic current was similar to that of the wild type colicin A.
Unitary currents (insets in Fig. 4, A and B) of the wild type,
H1/H2, and H3/H10 mutants had similar amplitude corresponding to a unitary conductance of 5.1 6 0.6 pS. By contrast,
the disulfide bonds connecting either helices 3 and 9 or helices
2 and 10 prevented the formation of functional channels, even
in a permanently depolarized bilayer (first part of current trace
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FIG. 3. Kinetics of the quenching of the intrinsic fluorescence
of double-cysteine mutants and wild type colicin A incubated
with or without DTT by Br-DOPG vesicles. To 400 ml of a colicin
solution, 25 mg/ml in 50 mM Tris acetate buffer (pH 5.0) pretreated with
or without 25 mM DTT were added 20 ml of a 10 mg/ml vesicle suspension in the same buffer (Ri 5 450), and the tryptophan emission fluorescence was recorded as a function of time. Spectra are normalized to
give identical fluorescence at t 5 0.
TABLE IV
Insertion data of the cysteine mutants and wild type colicin A
The residual fluorescence (RF) of each protein, untreated or treated
with DTT, inserted into Br-DOPG vesicles were calculated as previously described (4).
Insertion rate constant
Mutants
2DTT

1DTT

2DTT

0.0134
0.0166
0.0652
0.0364
0.0142
0.0125

0.46
0.15
0.47
0.85
0.55
0.58

21

(k) s

Wild type
Thermo (wild type)
H1/H2
H2/H10
H3/H9
H3/H10

0.0113
0.0175
0.0745
No insertion
0.0158
0.0166

Residual
fluorescence
1DTT

F`/F0

0.43
0.19
0.50
0.45
0.48
0.55

FIG. 4. Pore-forming activity of double-cysteine mutants incorporated in planar lipid bilayers. A, control recording of the
current generated by the wild type protein. The first depolarizing step
to 190 mV induced a slowly rising current, whereas the current in the
second 190 mV step had a fast onset (see text for details). The current
deactivated upon steping back to 290 mV. Inset, unitary currents under
control conditions (upper trace) and after incubating the protein with
DTT (2 mM, 30 min, 30 °C). B, current induced by the oxidized H1/H2
mutant subjected to the same voltage program as in A. Inset, unitary
currents resulting from the opening of channels formed by the oxidized
H1/H2 protein. C, behavior of the oxidized H3/H9 mutant in response to
a 190 mV step. The oxidized mutant was inactive (left-hand part of the
current trace). Adding DTT (2 mM) to the cis compartment induced an
outward current at 190 mV whose amplitude and activation rate increased with time (right-hand part of the recording). The current deactivated at 290 mV. Inset, unitary currents from DTT (2 mM)-treated
H3/H9 mutant.

open state and incomplete deactivation at large negative potentials (not illustrated).
DISCUSSION

in Fig. 4C). Preincubating the mutants with DTT or adding
DTT to the mutant-containing cis side of the bilayer (Fig. 4C)
restored the ability of the protein to incorporate in the bilayer.
The resulting channel had a unitary conductance similar to
that of wild type colicin A (inset in Fig. 4C). This process was,
however, slow, and several depolarizations were required for
the mutants to induce large currents. Although we did not
performed a systematic study, it appeared that the voltage
gating of the reduced H3/H9 and H2/H10 mutants differed
from that of the wild type protein, with fast flickering in the

Soluble pore-forming colicins undergo conformational
changes during their membrane insertion. They are unfolded
during their reception and translocation through the E. coli
envelope (19, 24). In the presence of membrane potential, the
colicin A C-terminal domain inserts into the membrane and
forms a conducting channel (4, 17, 27, 28). In order to analyze
the conformational changes associated with these different
steps, four disulfide bonds were introduced in the colicin A
C-terminal domain. The disulfide bonds were designed to connect the first three helices of the pore-forming domain to neighboring helices. The aim of these disulfide bonds was to restrict
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the degree of freedom of the first three helices of the colicin A
C-terminal domain and to determine the influence of these
helices in the colicin A translocation, membrane insertion,
and/or channel formation.
In the first part of this paper we demonstrated that all the
disulfide bonds were able to prevent the in vivo colicin A activity without affecting the colicin A translocation through the E.
coli envelope. Indeed, the oxidized colicins were inactive, but as
DTT was added in vitro, they recovered full channel activity as
judged from their capacity to induce an efflux of cytoplasmic K1
of the same amplitude as the wild type colicin. Channel activity
was also recovered by incubating the oxidized colicins with E.
coli cells and then adding DTT. The translocation of the wild
type colicin A and the mutants required 27–32 s. Interestingly,
when the oxidized colicins were incubated with bacteria for a
time longer than that needed for full translocation (see above),
the efflux of K1 started only 8 –10 s after DTT addition. This
short delay, which represents the time needed for DTT action,
indicated that the oxidized colicins were translocated and already close to the inner membrane when DTT was added to the
external medium. This result is similar to that obtained with
four other disulfide bonds connecting helices 1 and 9, helices 5
and 6, helices 7 and 8, and helices 9 and 10 (4, 19).
In the second part of this paper, we have studied the effect of
the disulfide bonds on the colicin A membrane insertion and
channel opening in vitro. The results confirm that the pore
formation includes at least two steps: a voltage-independent
membrane insertion and a voltage-dependent channel opening.
The disulfide bond that connects helices 3 and 9 did not prevent
the colicin A membrane insertion but blocked the channel
opening. The same result has been previously described with
the disulfide bonds connecting helices 5 and 6, helices 7 and 8,
and helices 9 and 10, respectively (4).
In the following discussion, we will first analyze the implication of this work on the voltage-independent membrane insertion of colicin A into the membrane and how this is compatible with the umbrella model described by Parker et al. (3, 8)
and supported by experiments on colicin E1 (9, 10, 27, 29, 30)
or with the penknife model proposed by Lakey et al. (11) and
supported by experiments on colicin A (12, 31, 32).
The fluorescence quenching assay with brominated lipid vesicles has been analyzed in detail by González-Mañas et al. (20,
21). This method detects the actual membrane insertion and
not the adsorption of colicin to the vesicle surface. The charged
amphipathic helices 3–7, which contain the three tryptophan
residues of the pore-forming domain of colicin A, most probably
sit in the membrane with the apolar region facing the hydrophobic core of the bilayer, exposing the fluorophores to the
bromine, and the polar face in contact with the solvent protecting the tryptophans from soluble quenchers (21, 33).
The two models considered that the voltage-independent
membrane insertion is driven by the opening of the molecule
extending helices 1 and 2 away from the other helices. In
agreement with these models, locking helices 2 and 10 together
prevents the colicin A membrane insertion, whereas locking
helices 1 and 2 and helices 3 and 10 has no measurable effect on
membrane insertion. The result obtained with the disulfide
bond connecting helices 3 and 9 supports the penknife model.
Indeed, the umbrella model predicts a large distance increase
between helix 3 and 9 upon membrane insertion. This is not
compatible with the ability of the H3/H9 mutant to insert into
the membrane. In contrast, the penknife model suggests that
the hydrophobic helices 8 and 9 remain close together with
helices 3–7 and helix 10 upon membrane insertion. Our results
confirm those obtained with the disulfide bonds previously
introduced in the colicin A C-terminal domain. Indeed, the

15405

disulfide bonds that connect helices 1 and 9 prevented the
colicin A membrane insertion, whereas the disulfide bonds that
connect helices 5 and 6, helices 7 and 8, and helices 9 and 10 did
not (4).
In the presence of membrane potential, some helices of the
colicin C-terminal domain insert into the membrane and form
a conducting channel. Many studies have focused on the identification of the helices forming the open state of the channels
(17, 26, 29, 34). On the basis of biochemical labeling experiments, Merill and Cramer have proposed that the colicin E1
channel was formed by four helices, the hydrophobic helical
hairpin and an amphipathic helical hairpin composed by helices 5 and 6 (29). This amphipathic helical hairpin has been
identified as the voltage-sensitive segment. Subsequent experiments have confirmed this result (27, 35). Recently, Slatin et
al. (17) have demonstrated that at least 31 amino acids of the
colicin Ia C-terminal domain were translocated across the
membrane after application of a trans-negative potential. This
result indicates that the voltage gating is not only associated
with the insertion of a helical hairpin into the membrane but
also with the translocation of part of the protein across the
membrane.
The results obtained in this paper suggest that helices 1, 2,
3, and 10 remain at the membrane surface after application of
a trans-negative voltage. Indeed, the disulfide bonds that connected helices 1 and 2 and helices 3 and 10 did not prevent the
membrane insertion or the channel opening. In contrast, the
disulfide bond between helices 3 and 9 did not prevent the
membrane insertion but prevents the channel opening, suggesting that helix 9 should move away from helix 3 upon
channel opening by the membrane potential. Probably, the
helical hairpin (helices 8 and 9) becomes perpendicular to the
plane of the lipid bilayer. The same interpretation could be
given with the results obtained with the disulfide bonds connecting helices 9 and 10 and helices 7 and 8 (4) and could
suggest that helix 7 is also at the membrane surface. Nevertheless, we cannot rule out the possibility of helix 7 forming
part of the channel. Taking together these results, we can
postulate that the open state of the colicin A channel is formed
by four helices, helices 8 and 9 and helices 5 and 6.
It has been previously described that the first three helices of
the colicin A C-terminal domain were not involved in ion conduction through the channel (36). According to this result, the
two disulfide bonds connecting helices 1 and 2 and helices 3 and
10 did not prevent the in vitro channel opening of the toxin.
However, these disulfide bonds blocked the in vivo activity of
the colicin A without affecting its translocation through the E.
coli envelope. Previous results have indicated that colicin A
and Ia remained in contact with the outer membrane when
they formed a channel in the inner membrane of sensitive cells
(24, 37–39). In order to explain the results obtained with the
disulfide bonds connecting helices 1 and 2 and helices 3 and 10,
we can speculate that helices 1, 2, and 3 span the periplasm of
E. coli and connect the central domain of the toxin fixed to the
outer membrane to helices 4 –9 of the C-terminal domain inserted into the inner membrane.
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